Sanofi has quickly withdrawn a pledge by its CEO Paul Hudson that the U.S. would be the first to receive its potential COVID-19 vaccine. Read More

Rick Bright, former director of HHS’s Biomedical Advanced Research and Development Authority (BARDA), told lawmakers in a hearing yesterday that the frequently cited 12- to 18-month timeline for developing a COVID-19 vaccine is unlikely to pan out. Read More

Democratic lawmakers are pressing HHS Secretary Alex Azar on how the department is handling the distribution of remdesivir. Read More

As a growing number of studies raise alarms about using hydroxychloroquine to treat COVID-19, the National Institutes of Health (NIH) is starting a large clinical trial to evaluate the drug in combination with the antibiotic azithromycin. Read More

A clinical trial of thousands of patients found that convalescent plasma is safe for COVID-19 patients. Read More

The FDA is working with the Centers for Disease Control and Prevention (CDC) to determine how it will restart routine on-site inspections of drug manufacturing facilities, the agency has announced. Read More